1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEUROCRINE BIOSCIENCES, INC.

Neurocrine Biosciences, Inc.

XNAS: NBIX

Mid-range Performer
Download real time

106.14 0.38 (0.36%)

32.81% Fall from 52W High

169.5K XNAS Volume

XNAS 25 Apr, 2025 12:00 PM (EDT)

Watchlist

Portfolio

Share
16S
6W
5O
0T
10,501.3

Market Cap

High in industry
30.8

PE TTM

High in industry
0.8

PEG TTM

PEG TTM is less than 1
4.1

Price to Book

Below industry Median
-0.2

Beta 1Year

Very Low volatility
Board Meeting
The next board meeting for Neurocrine Biosciences, Inc. is on 05 May 2025 for the purpose of Neurocrine Biosciences Inc First Quarter Earnings Results for 2025 See details

Neurocrine Biosciences, Inc. - NBIX - stock price prediction, stock price target, analyst ratings from 25 analysts

Neurocrine Biosciences, Inc. has a share price target of US$ 157, revenue growth forecast of 13.0%, and profit growth estimate of 18.0% for FY25, based on top 25 analyst calls.

Forecaster Screeners